EMN

Eastman Chemical Company - Q2 2004 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2004. Eastman Chemical Company operates in three divisions: Eastman Division (CASPI, PCI, SP segments), Voridian Division (Polymers, Fibers segments), and Developing Businesses Division. A significant strategic event during this period was the agreement to sell certain businesses and product lines within the CASPI segment, which was completed on July 31, 2004.

Key Financial Metrics

Note: Q2 2004 Net Earnings include a significant non-cash tax benefit of $82 million related to assets held for sale.

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 13% in Q2 and 12% YTD compared to 2003, driven primarily by increased sales volume across all segments and favorable foreign currency exchange rates (particularly the Euro).
• Restructuring Charges: The Company recognized $79 million in asset impairments and restructuring charges in Q2 2004 (up from $16 million in Q2 2003). YTD charges totaled $146 million. These were primarily driven by the CASPI segment divestiture ($62 million impairment) and the closure of the Hartlepool, UK facility ($40 million impairment).
• Profitability: While Net Earnings increased significantly due to the tax benefit, Operating Earnings declined 45% in Q2 and 58% YTD due to the aforementioned restructuring charges and higher raw material/energy costs.
• Liquidity: Cash and cash equivalents decreased from $558 million to $145 million, largely due to the repayment of $500 million in notes maturing in January 2004 and dividend payments.

Guidance, Outlook, and Risks

• Q3 2004 Guidance: Management expects net earnings per share to be between $0.63 and $0.82.
• 2004 Outlook: The Company expects historically high raw material and energy costs to continue. It anticipates no contributions to U.S. defined benefit pension plans in 2004. Depreciation and amortization are expected to decrease by approximately $35 million compared to 2003.
• Segment Strategy:
  • CASPI: Completion of the divestiture is expected to improve profitability and cash flows.
  • Polymers: Focus on lowering costs; PET polymers expected to grow with market demand.
  • Developing Businesses: Cendian (logistics subsidiary) has not met margin expectations; the Company is evaluating options including restructuring or divestiture.
• Risks: Key risks include the ability to pass on higher raw material costs to customers, foreign currency fluctuations, and the outcome of pending litigation (Sorbates and Asbestos), though management does not currently expect a material adverse impact from these legal matters.

Investor Verification Checklist

• Tax Benefit Sustainability: Verify the $82 million deferred tax benefit related to capital loss carryforwards from the CASPI divestiture; this is a non-recurring item significantly boosting Q2 net income.
• Restructuring Execution: Monitor the completion of the CASPI divestiture (closed July 31, 2004) and the Hartlepool facility closure to assess the realization of projected cost savings.
• Raw Material Margins: Track the Company's ability to implement price increases to offset rising costs for paraxylene, ethylene glycol, and natural gas, which are pressuring gross margins.
• Debt Maturity: Note the repayment of $500 million in notes in Jan 2004 and the remaining debt structure, including $271 million in commercial paper/credit facility borrowings.
• Developing Businesses: Watch for updates on Cendian Corporation, as the segment is currently operating at a loss and facing potential restructuring.